data13F

Catalyst Pharmaceuticals Inc

Held by 0 of 60 tracked investors in their latest 13F filing

Investors holding0
Combined shares0
Combined reported value$0

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
George Soros0.00Closed0–Q3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026George Soros narrow view Closed00.18
Q2 2026George Soros narrow view New344,5930.18
Q2 2026Terry Smith Closed00.16
Q2 2026Paul Tudor Jones narrow view Closed00.00
Q1 2026Terry Smith Reduced 74.9%844,8870.49
Q1 2026Paul Tudor Jones narrow view New20,3950.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026George Soros narrow view New344,5930.18
Q1 2026Paul Tudor Jones narrow view New20,3950.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026George Soros narrow view Closed00.18
Q2 2026Terry Smith Closed00.16
Q2 2026Paul Tudor Jones narrow view Closed00.00
Q1 2026Terry Smith Reduced 74.9%844,8870.49

History

2 peakQ2 2026: 1 tracked investors
Q3 2022: 1 tracked investorsQ4 2024: 1 tracked investorsQ1 2025: 2 tracked investorsQ2 2025: 2 tracked investorsQ3 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 2 tracked investorsQ2 2026: 1 tracked investors
20222026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
George Soros–344.6K––––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).